Skip to Content

Metoclopramide Injection

Last Updated: January 16, 2018
Status: Resolved

Metoclopramide Injection

Products Affected - Description
  • Metoclopramide injection, Fresenius Kabi
    5 mg/mL, 2 mL Simplist prefilled syringe, 24 count (NDC 76045-0101-20)

    Metoclopramide injection, Pfizer
    5 mg/mL, 2 mL vial, 25 count (NDC 00409-3414-01)

    Metoclopramide injection, Teva
    5 mg/mL, 2 mL vial, 25 count (NDC 00703-4502-04)

Reason for the Shortage
    • Pfizer has metoclopramide injection on shortage due to manufacturing delays.
    • Teva has metoclopramide injection on shortage due to increased demand.
Available Products
  • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Fresenius Kabi has metoclopramide 5 mg/mL 2 mL syringes on back order and the company estimates a release date of early-March 2018.
    • Pfizer has metoclopramide 5 mg/mL 2 mL vials on back order and the company estimates a release date of late-January 2018.
    • Teva has metoclopramide 5 mg/mL 2 mL vials on allocation.

Implications for Patient Care

  •  

Updated

January 16 and 6, 2018; November 22, October 2, September 25 and 1, July 31 and 16, 2017, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide